RapamycinFungusV1, Main, Exploration, bibRecord, 000309

Kaposi Sarcoma in HIV-positive Solid-Organ Transplant Recipients: A French Multicentric National Study and Literature Review.

Identifieur interne : 000309 ( Main/Exploration ); précédent : 000308; suivant : 000310

Kaposi Sarcoma in HIV-positive Solid-Organ Transplant Recipients: A French Multicentric National Study and Literature Review.

Auteurs : Chloé Charpentier [France] ; Julie Delyon [France] ; Denis Glotz [France] ; Marie-Noelle Peraldi [France] ; Jean-Philippe Rerolle [France] ; Benoît Barrou [France] ; Emilie Ducroux [France] ; Audrey Coilly [France] ; Camille Legeai [France] ; Stéphane Barete [France] ; Céleste Lebbé [France]

Source :

Transplantation [ 1534-6080 ] ; 2019.

RBID : pubmed:30273235

Descripteurs français

KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Agents antiVIH (effets indésirables), Bases de données factuelles (MeSH), Facteurs de risque (MeSH), Facteurs temps (MeSH), Femelle (MeSH), France (épidémiologie), Herpèsvirus humain de type 8 (immunologie), Herpèsvirus humain de type 8 (pathogénicité), Humains (MeSH), Immunosuppresseurs (effets indésirables), Infections à VIH (immunologie), Infections à VIH (traitement médicamenteux), Infections à VIH (épidémiologie), Mâle (MeSH), Prévalence (MeSH), Résultat thérapeutique (MeSH), Sarcome de Kaposi (immunologie), Sarcome de Kaposi (thérapie), Sarcome de Kaposi (virologie), Sarcome de Kaposi (épidémiologie), Sujet immunodéprimé (MeSH), Sujet âgé (MeSH), Thérapie antirétrovirale hautement active (effets indésirables), Transplantation d'organe (effets indésirables), Études rétrospectives (MeSH).
MESH :
- effets indésirables : Agents antiVIH, Immunosuppresseurs, Thérapie antirétrovirale hautement active, Transplantation d'organe.
- immunologie : Herpèsvirus humain de type 8, Infections à VIH, Sarcome de Kaposi.
- pathogénicité : Herpèsvirus humain de type 8.
- thérapie : Sarcome de Kaposi.
- traitement médicamenteux : Infections à VIH.
- virologie : Sarcome de Kaposi.
- épidémiologie : France, Infections à VIH, Sarcome de Kaposi.
- Adulte, Adulte d'âge moyen, Bases de données factuelles, Facteurs de risque, Facteurs temps, Femelle, Humains, Mâle, Prévalence, Résultat thérapeutique, Sujet immunodéprimé, Sujet âgé, Études rétrospectives.
Wicri :
- geographic : France.

English descriptors

KwdEn :
- Adult (MeSH), Aged (MeSH), Anti-HIV Agents (adverse effects), Antiretroviral Therapy, Highly Active (adverse effects), Databases, Factual (MeSH), Female (MeSH), France (epidemiology), HIV Infections (drug therapy), HIV Infections (epidemiology), HIV Infections (immunology), Herpesvirus 8, Human (immunology), Herpesvirus 8, Human (pathogenicity), Humans (MeSH), Immunocompromised Host (MeSH), Immunosuppressive Agents (adverse effects), Male (MeSH), Middle Aged (MeSH), Organ Transplantation (adverse effects), Prevalence (MeSH), Retrospective Studies (MeSH), Risk Factors (MeSH), Sarcoma, Kaposi (epidemiology), Sarcoma, Kaposi (immunology), Sarcoma, Kaposi (therapy), Sarcoma, Kaposi (virology), Time Factors (MeSH), Treatment Outcome (MeSH).
MESH :
- chemical , adverse effects : Anti-HIV Agents, Immunosuppressive Agents.
- geographic , epidemiology : France.
- adverse effects : Antiretroviral Therapy, Highly Active, Organ Transplantation.
- drug therapy : HIV Infections.
- epidemiology : HIV Infections, Sarcoma, Kaposi.
- immunology : HIV Infections, Herpesvirus 8, Human, Sarcoma, Kaposi.
- pathogenicity : Herpesvirus 8, Human.
- therapy : Sarcoma, Kaposi.
- virology : Sarcoma, Kaposi.
- Adult, Aged, Databases, Factual, Female, Humans, Immunocompromised Host, Male, Middle Aged, Prevalence, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome.

Abstract

BACKGROUND

Kaposi sarcoma is a vascular tumor related to herpesvirus-8 and is promoted by immunosuppression. For the last 15 years, human immunodeficiency virus (HIV) patients have had access to organ transplantation. The dual immunosuppression of HIV and immunosuppressive treatments might increase the risk and severity of Kaposi sarcoma.

METHODS

We conducted a multicentric retrospective study by collecting cases from French databases and society members of transplanted patients, among which 7 HIV-infected patients who subsequently developed Kaposi sarcoma were included.

RESULTS

In the CRISTAL database (114 511 patients) and the DIVAT (Données Informatisées et VAlidées en Transplantation) database (19 077 patients), the prevalence of Kaposi sarcoma was 0.18% and 0.46%, respectively, in transplanted patients; these values compare with 0.66% and 0.50%, respectively, in transplanted patients with HIV. The median time from HIV infection to Kaposi sarcoma was 20 years. Kaposi sarcoma occurred during the first year after transplantation in most cases, whereas HIV viral load was undetectable. Only 2 patients had visceral involvement. Five patients were treated with conversion of calcineurin inhibitor to mammalian target of rapamycin inhibitor, and 5 patients were managed by decreasing immunosuppressive therapies. At 1 year, 4 patients had a complete response, and 3 had a partial response.

CONCLUSIONS

In our study, Kaposi sarcoma in transplanted patients with HIV did not show any aggressive features and was treated with the usual posttransplant Kaposi sarcoma management protocol.

DOI: 10.1097/TP.0000000000002468
PubMed: 30273235

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000445
to stream Main, to step Curation: 000445

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Kaposi Sarcoma in HIV-positive Solid-Organ Transplant Recipients: A French Multicentric National Study and Literature Review.</title>
<author><name sortKey="Charpentier, Chloe" sort="Charpentier, Chloe" uniqKey="Charpentier C" first="Chloé" last="Charpentier">Chloé Charpentier</name>
<affiliation wicri:level="3"><nlm:affiliation>APHP Department of Dermatology, Saint Louis Hospital, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>APHP Department of Dermatology, Saint Louis Hospital, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Delyon, Julie" sort="Delyon, Julie" uniqKey="Delyon J" first="Julie" last="Delyon">Julie Delyon</name>
<affiliation wicri:level="3"><nlm:affiliation>APHP Department of Dermatology, Saint Louis Hospital, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>APHP Department of Dermatology, Saint Louis Hospital, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>INSERM U976, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U976</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Paris Diderot University, Sorbonne Paris Cité, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Paris Diderot University, Sorbonne Paris Cité</wicri:regionArea>
<wicri:noRegion>Sorbonne Paris Cité</wicri:noRegion>
<wicri:noRegion>Sorbonne Paris Cité</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Glotz, Denis" sort="Glotz, Denis" uniqKey="Glotz D" first="Denis" last="Glotz">Denis Glotz</name>
<affiliation wicri:level="1"><nlm:affiliation>Paris Diderot University, Sorbonne Paris Cité, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Paris Diderot University, Sorbonne Paris Cité</wicri:regionArea>
<wicri:noRegion>Sorbonne Paris Cité</wicri:noRegion>
<wicri:noRegion>Sorbonne Paris Cité</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Department of Nephrology, Saint Louis Hospital, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Nephrology, Saint Louis Hospital, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Peraldi, Marie Noelle" sort="Peraldi, Marie Noelle" uniqKey="Peraldi M" first="Marie-Noelle" last="Peraldi">Marie-Noelle Peraldi</name>
<affiliation wicri:level="1"><nlm:affiliation>Paris Diderot University, Sorbonne Paris Cité, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Paris Diderot University, Sorbonne Paris Cité</wicri:regionArea>
<wicri:noRegion>Sorbonne Paris Cité</wicri:noRegion>
<wicri:noRegion>Sorbonne Paris Cité</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Department of Nephrology, Saint Louis Hospital, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Nephrology, Saint Louis Hospital, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rerolle, Jean Philippe" sort="Rerolle, Jean Philippe" uniqKey="Rerolle J" first="Jean-Philippe" last="Rerolle">Jean-Philippe Rerolle</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Nephrology, Dupuytren Hospital, Limoges, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Nephrology, Dupuytren Hospital, Limoges</wicri:regionArea>
<placeName><region type="region">Nouvelle-Aquitaine</region>
<region type="old region">Limousin</region>
<settlement type="city">Limoges</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Barrou, Benoit" sort="Barrou, Benoit" uniqKey="Barrou B" first="Benoît" last="Barrou">Benoît Barrou</name>
<affiliation wicri:level="3"><nlm:affiliation>UPMC, Department of Urology, Nephrology and Transplantation, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>UPMC, Department of Urology, Nephrology and Transplantation, Pitié-Salpêtrière Hospital, Sorbonne University, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ducroux, Emilie" sort="Ducroux, Emilie" uniqKey="Ducroux E" first="Emilie" last="Ducroux">Emilie Ducroux</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Dermatology, Edouard Herriot Hospital, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Dermatology, Edouard Herriot Hospital, Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Coilly, Audrey" sort="Coilly, Audrey" uniqKey="Coilly A" first="Audrey" last="Coilly">Audrey Coilly</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Hepatology and Gastrology, Paul Brousse Hospital, Villejuif, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Hepatology and Gastrology, Paul Brousse Hospital, Villejuif</wicri:regionArea>
<placeName><settlement type="city">Villejuif</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Legeai, Camille" sort="Legeai, Camille" uniqKey="Legeai C" first="Camille" last="Legeai">Camille Legeai</name>
<affiliation wicri:level="1"><nlm:affiliation>Biomedicine Agency. Saint-Denis La Plaine, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Biomedicine Agency. Saint-Denis La Plaine</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Barete, Stephane" sort="Barete, Stephane" uniqKey="Barete S" first="Stéphane" last="Barete">Stéphane Barete</name>
<affiliation wicri:level="3"><nlm:affiliation>UPMC, Unit of Dermatology, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>UPMC, Unit of Dermatology, Pitié-Salpêtrière Hospital, Sorbonne University, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lebbe, Celeste" sort="Lebbe, Celeste" uniqKey="Lebbe C" first="Céleste" last="Lebbé">Céleste Lebbé</name>
<affiliation wicri:level="3"><nlm:affiliation>APHP Department of Dermatology, Saint Louis Hospital, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>APHP Department of Dermatology, Saint Louis Hospital, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>INSERM U976, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U976</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Paris Diderot University, Sorbonne Paris Cité, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Paris Diderot University, Sorbonne Paris Cité</wicri:regionArea>
<wicri:noRegion>Sorbonne Paris Cité</wicri:noRegion>
<wicri:noRegion>Sorbonne Paris Cité</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:30273235</idno>
<idno type="pmid">30273235</idno>
<idno type="doi">10.1097/TP.0000000000002468</idno>
<idno type="wicri:Area/Main/Corpus">000445</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000445</idno>
<idno type="wicri:Area/Main/Curation">000445</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000445</idno>
<idno type="wicri:Area/Main/Exploration">000445</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Kaposi Sarcoma in HIV-positive Solid-Organ Transplant Recipients: A French Multicentric National Study and Literature Review.</title>
<author><name sortKey="Charpentier, Chloe" sort="Charpentier, Chloe" uniqKey="Charpentier C" first="Chloé" last="Charpentier">Chloé Charpentier</name>
<affiliation wicri:level="3"><nlm:affiliation>APHP Department of Dermatology, Saint Louis Hospital, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>APHP Department of Dermatology, Saint Louis Hospital, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Delyon, Julie" sort="Delyon, Julie" uniqKey="Delyon J" first="Julie" last="Delyon">Julie Delyon</name>
<affiliation wicri:level="3"><nlm:affiliation>APHP Department of Dermatology, Saint Louis Hospital, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>APHP Department of Dermatology, Saint Louis Hospital, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>INSERM U976, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U976</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Paris Diderot University, Sorbonne Paris Cité, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Paris Diderot University, Sorbonne Paris Cité</wicri:regionArea>
<wicri:noRegion>Sorbonne Paris Cité</wicri:noRegion>
<wicri:noRegion>Sorbonne Paris Cité</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Glotz, Denis" sort="Glotz, Denis" uniqKey="Glotz D" first="Denis" last="Glotz">Denis Glotz</name>
<affiliation wicri:level="1"><nlm:affiliation>Paris Diderot University, Sorbonne Paris Cité, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Paris Diderot University, Sorbonne Paris Cité</wicri:regionArea>
<wicri:noRegion>Sorbonne Paris Cité</wicri:noRegion>
<wicri:noRegion>Sorbonne Paris Cité</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Department of Nephrology, Saint Louis Hospital, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Nephrology, Saint Louis Hospital, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Peraldi, Marie Noelle" sort="Peraldi, Marie Noelle" uniqKey="Peraldi M" first="Marie-Noelle" last="Peraldi">Marie-Noelle Peraldi</name>
<affiliation wicri:level="1"><nlm:affiliation>Paris Diderot University, Sorbonne Paris Cité, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Paris Diderot University, Sorbonne Paris Cité</wicri:regionArea>
<wicri:noRegion>Sorbonne Paris Cité</wicri:noRegion>
<wicri:noRegion>Sorbonne Paris Cité</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><nlm:affiliation>Department of Nephrology, Saint Louis Hospital, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Nephrology, Saint Louis Hospital, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rerolle, Jean Philippe" sort="Rerolle, Jean Philippe" uniqKey="Rerolle J" first="Jean-Philippe" last="Rerolle">Jean-Philippe Rerolle</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Nephrology, Dupuytren Hospital, Limoges, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Nephrology, Dupuytren Hospital, Limoges</wicri:regionArea>
<placeName><region type="region">Nouvelle-Aquitaine</region>
<region type="old region">Limousin</region>
<settlement type="city">Limoges</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Barrou, Benoit" sort="Barrou, Benoit" uniqKey="Barrou B" first="Benoît" last="Barrou">Benoît Barrou</name>
<affiliation wicri:level="3"><nlm:affiliation>UPMC, Department of Urology, Nephrology and Transplantation, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>UPMC, Department of Urology, Nephrology and Transplantation, Pitié-Salpêtrière Hospital, Sorbonne University, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ducroux, Emilie" sort="Ducroux, Emilie" uniqKey="Ducroux E" first="Emilie" last="Ducroux">Emilie Ducroux</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Dermatology, Edouard Herriot Hospital, Lyon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Dermatology, Edouard Herriot Hospital, Lyon</wicri:regionArea>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Coilly, Audrey" sort="Coilly, Audrey" uniqKey="Coilly A" first="Audrey" last="Coilly">Audrey Coilly</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Hepatology and Gastrology, Paul Brousse Hospital, Villejuif, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Hepatology and Gastrology, Paul Brousse Hospital, Villejuif</wicri:regionArea>
<placeName><settlement type="city">Villejuif</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Legeai, Camille" sort="Legeai, Camille" uniqKey="Legeai C" first="Camille" last="Legeai">Camille Legeai</name>
<affiliation wicri:level="1"><nlm:affiliation>Biomedicine Agency. Saint-Denis La Plaine, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Biomedicine Agency. Saint-Denis La Plaine</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Barete, Stephane" sort="Barete, Stephane" uniqKey="Barete S" first="Stéphane" last="Barete">Stéphane Barete</name>
<affiliation wicri:level="3"><nlm:affiliation>UPMC, Unit of Dermatology, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>UPMC, Unit of Dermatology, Pitié-Salpêtrière Hospital, Sorbonne University, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lebbe, Celeste" sort="Lebbe, Celeste" uniqKey="Lebbe C" first="Céleste" last="Lebbé">Céleste Lebbé</name>
<affiliation wicri:level="3"><nlm:affiliation>APHP Department of Dermatology, Saint Louis Hospital, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>APHP Department of Dermatology, Saint Louis Hospital, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>INSERM U976, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U976</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Paris Diderot University, Sorbonne Paris Cité, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Paris Diderot University, Sorbonne Paris Cité</wicri:regionArea>
<wicri:noRegion>Sorbonne Paris Cité</wicri:noRegion>
<wicri:noRegion>Sorbonne Paris Cité</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Transplantation</title>
<idno type="eISSN">1534-6080</idno>
<imprint><date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Anti-HIV Agents (adverse effects)</term>
<term>Antiretroviral Therapy, Highly Active (adverse effects)</term>
<term>Databases, Factual (MeSH)</term>
<term>Female (MeSH)</term>
<term>France (epidemiology)</term>
<term>HIV Infections (drug therapy)</term>
<term>HIV Infections (epidemiology)</term>
<term>HIV Infections (immunology)</term>
<term>Herpesvirus 8, Human (immunology)</term>
<term>Herpesvirus 8, Human (pathogenicity)</term>
<term>Humans (MeSH)</term>
<term>Immunocompromised Host (MeSH)</term>
<term>Immunosuppressive Agents (adverse effects)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Organ Transplantation (adverse effects)</term>
<term>Prevalence (MeSH)</term>
<term>Retrospective Studies (MeSH)</term>
<term>Risk Factors (MeSH)</term>
<term>Sarcoma, Kaposi (epidemiology)</term>
<term>Sarcoma, Kaposi (immunology)</term>
<term>Sarcoma, Kaposi (therapy)</term>
<term>Sarcoma, Kaposi (virology)</term>
<term>Time Factors (MeSH)</term>
<term>Treatment Outcome (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Agents antiVIH (effets indésirables)</term>
<term>Bases de données factuelles (MeSH)</term>
<term>Facteurs de risque (MeSH)</term>
<term>Facteurs temps (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>France (épidémiologie)</term>
<term>Herpèsvirus humain de type 8 (immunologie)</term>
<term>Herpèsvirus humain de type 8 (pathogénicité)</term>
<term>Humains (MeSH)</term>
<term>Immunosuppresseurs (effets indésirables)</term>
<term>Infections à VIH (immunologie)</term>
<term>Infections à VIH (traitement médicamenteux)</term>
<term>Infections à VIH (épidémiologie)</term>
<term>Mâle (MeSH)</term>
<term>Prévalence (MeSH)</term>
<term>Résultat thérapeutique (MeSH)</term>
<term>Sarcome de Kaposi (immunologie)</term>
<term>Sarcome de Kaposi (thérapie)</term>
<term>Sarcome de Kaposi (virologie)</term>
<term>Sarcome de Kaposi (épidémiologie)</term>
<term>Sujet immunodéprimé (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Thérapie antirétrovirale hautement active (effets indésirables)</term>
<term>Transplantation d'organe (effets indésirables)</term>
<term>Études rétrospectives (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Anti-HIV Agents</term>
<term>Immunosuppressive Agents</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>France</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Antiretroviral Therapy, Highly Active</term>
<term>Organ Transplantation</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Agents antiVIH</term>
<term>Immunosuppresseurs</term>
<term>Thérapie antirétrovirale hautement active</term>
<term>Transplantation d'organe</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>HIV Infections</term>
<term>Sarcoma, Kaposi</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Herpèsvirus humain de type 8</term>
<term>Infections à VIH</term>
<term>Sarcome de Kaposi</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>HIV Infections</term>
<term>Herpesvirus 8, Human</term>
<term>Sarcoma, Kaposi</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Herpesvirus 8, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Herpèsvirus humain de type 8</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Sarcoma, Kaposi</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Sarcome de Kaposi</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à VIH</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Sarcome de Kaposi</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Sarcoma, Kaposi</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>France</term>
<term>Infections à VIH</term>
<term>Sarcome de Kaposi</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Databases, Factual</term>
<term>Female</term>
<term>Humans</term>
<term>Immunocompromised Host</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Prevalence</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Bases de données factuelles</term>
<term>Facteurs de risque</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Prévalence</term>
<term>Résultat thérapeutique</term>
<term>Sujet immunodéprimé</term>
<term>Sujet âgé</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>France</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b>
</p>
<p>Kaposi sarcoma is a vascular tumor related to herpesvirus-8 and is promoted by immunosuppression. For the last 15 years, human immunodeficiency virus (HIV) patients have had access to organ transplantation. The dual immunosuppression of HIV and immunosuppressive treatments might increase the risk and severity of Kaposi sarcoma.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>We conducted a multicentric retrospective study by collecting cases from French databases and society members of transplanted patients, among which 7 HIV-infected patients who subsequently developed Kaposi sarcoma were included.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>In the CRISTAL database (114 511 patients) and the DIVAT (Données Informatisées et VAlidées en Transplantation) database (19 077 patients), the prevalence of Kaposi sarcoma was 0.18% and 0.46%, respectively, in transplanted patients; these values compare with 0.66% and 0.50%, respectively, in transplanted patients with HIV. The median time from HIV infection to Kaposi sarcoma was 20 years. Kaposi sarcoma occurred during the first year after transplantation in most cases, whereas HIV viral load was undetectable. Only 2 patients had visceral involvement. Five patients were treated with conversion of calcineurin inhibitor to mammalian target of rapamycin inhibitor, and 5 patients were managed by decreasing immunosuppressive therapies. At 1 year, 4 patients had a complete response, and 3 had a partial response.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b>
</p>
<p>In our study, Kaposi sarcoma in transplanted patients with HIV did not show any aggressive features and was treated with the usual posttransplant Kaposi sarcoma management protocol.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30273235</PMID>
<DateCompleted><Year>2019</Year>
<Month>05</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>05</Month>
<Day>28</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1534-6080</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>103</Volume>
<Issue>1</Issue>
<PubDate><Year>2019</Year>
<Month>01</Month>
</PubDate>
</JournalIssue>
<Title>Transplantation</Title>
<ISOAbbreviation>Transplantation</ISOAbbreviation>
</Journal>
<ArticleTitle>Kaposi Sarcoma in HIV-positive Solid-Organ Transplant Recipients: A French Multicentric National Study and Literature Review.</ArticleTitle>
<Pagination><MedlinePgn>e22-e28</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/TP.0000000000002468</ELocationID>
<Abstract><AbstractText Label="BACKGROUND">Kaposi sarcoma is a vascular tumor related to herpesvirus-8 and is promoted by immunosuppression. For the last 15 years, human immunodeficiency virus (HIV) patients have had access to organ transplantation. The dual immunosuppression of HIV and immunosuppressive treatments might increase the risk and severity of Kaposi sarcoma.</AbstractText>
<AbstractText Label="METHODS">We conducted a multicentric retrospective study by collecting cases from French databases and society members of transplanted patients, among which 7 HIV-infected patients who subsequently developed Kaposi sarcoma were included.</AbstractText>
<AbstractText Label="RESULTS">In the CRISTAL database (114 511 patients) and the DIVAT (Données Informatisées et VAlidées en Transplantation) database (19 077 patients), the prevalence of Kaposi sarcoma was 0.18% and 0.46%, respectively, in transplanted patients; these values compare with 0.66% and 0.50%, respectively, in transplanted patients with HIV. The median time from HIV infection to Kaposi sarcoma was 20 years. Kaposi sarcoma occurred during the first year after transplantation in most cases, whereas HIV viral load was undetectable. Only 2 patients had visceral involvement. Five patients were treated with conversion of calcineurin inhibitor to mammalian target of rapamycin inhibitor, and 5 patients were managed by decreasing immunosuppressive therapies. At 1 year, 4 patients had a complete response, and 3 had a partial response.</AbstractText>
<AbstractText Label="CONCLUSIONS">In our study, Kaposi sarcoma in transplanted patients with HIV did not show any aggressive features and was treated with the usual posttransplant Kaposi sarcoma management protocol.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Charpentier</LastName>
<ForeName>Chloé</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>APHP Department of Dermatology, Saint Louis Hospital, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Delyon</LastName>
<ForeName>Julie</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>APHP Department of Dermatology, Saint Louis Hospital, Paris, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>INSERM U976, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Paris Diderot University, Sorbonne Paris Cité, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Glotz</LastName>
<ForeName>Denis</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Paris Diderot University, Sorbonne Paris Cité, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Nephrology, Saint Louis Hospital, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Peraldi</LastName>
<ForeName>Marie-Noelle</ForeName>
<Initials>MN</Initials>
<AffiliationInfo><Affiliation>Paris Diderot University, Sorbonne Paris Cité, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Nephrology, Saint Louis Hospital, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rerolle</LastName>
<ForeName>Jean-Philippe</ForeName>
<Initials>JP</Initials>
<AffiliationInfo><Affiliation>Department of Nephrology, Dupuytren Hospital, Limoges, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Barrou</LastName>
<ForeName>Benoît</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>UPMC, Department of Urology, Nephrology and Transplantation, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ducroux</LastName>
<ForeName>Emilie</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Department of Dermatology, Edouard Herriot Hospital, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Coilly</LastName>
<ForeName>Audrey</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Hepatology and Gastrology, Paul Brousse Hospital, Villejuif, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Legeai</LastName>
<ForeName>Camille</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Biomedicine Agency. Saint-Denis La Plaine, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Barete</LastName>
<ForeName>Stéphane</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>UPMC, Unit of Dermatology, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lebbé</LastName>
<ForeName>Céleste</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>APHP Department of Dermatology, Saint Louis Hospital, Paris, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>INSERM U976, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Paris Diderot University, Sorbonne Paris Cité, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Transplantation</MedlineTA>
<NlmUniqueID>0132144</NlmUniqueID>
<ISSNLinking>0041-1337</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019380">Anti-HIV Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019380" MajorTopicYN="N">Anti-HIV Agents</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D023241" MajorTopicYN="N">Antiretroviral Therapy, Highly Active</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019288" MajorTopicYN="N">Herpesvirus 8, Human</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016867" MajorTopicYN="Y">Immunocompromised Host</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016377" MajorTopicYN="N">Organ Transplantation</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012514" MajorTopicYN="N">Sarcoma, Kaposi</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year>
<Month>10</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2019</Year>
<Month>5</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2018</Year>
<Month>10</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">30273235</ArticleId>
<ArticleId IdType="doi">10.1097/TP.0000000000002468</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
</country>
<region><li>Auvergne-Rhône-Alpes</li>
<li>Limousin</li>
<li>Nouvelle-Aquitaine</li>
<li>Rhône-Alpes</li>
<li>Île-de-France</li>
</region>
<settlement><li>Limoges</li>
<li>Lyon</li>
<li>Paris</li>
<li>Villejuif</li>
</settlement>
</list>
<tree><country name="France"><region name="Île-de-France"><name sortKey="Charpentier, Chloe" sort="Charpentier, Chloe" uniqKey="Charpentier C" first="Chloé" last="Charpentier">Chloé Charpentier</name>
</region>
<name sortKey="Barete, Stephane" sort="Barete, Stephane" uniqKey="Barete S" first="Stéphane" last="Barete">Stéphane Barete</name>
<name sortKey="Barrou, Benoit" sort="Barrou, Benoit" uniqKey="Barrou B" first="Benoît" last="Barrou">Benoît Barrou</name>
<name sortKey="Coilly, Audrey" sort="Coilly, Audrey" uniqKey="Coilly A" first="Audrey" last="Coilly">Audrey Coilly</name>
<name sortKey="Delyon, Julie" sort="Delyon, Julie" uniqKey="Delyon J" first="Julie" last="Delyon">Julie Delyon</name>
<name sortKey="Delyon, Julie" sort="Delyon, Julie" uniqKey="Delyon J" first="Julie" last="Delyon">Julie Delyon</name>
<name sortKey="Delyon, Julie" sort="Delyon, Julie" uniqKey="Delyon J" first="Julie" last="Delyon">Julie Delyon</name>
<name sortKey="Ducroux, Emilie" sort="Ducroux, Emilie" uniqKey="Ducroux E" first="Emilie" last="Ducroux">Emilie Ducroux</name>
<name sortKey="Glotz, Denis" sort="Glotz, Denis" uniqKey="Glotz D" first="Denis" last="Glotz">Denis Glotz</name>
<name sortKey="Glotz, Denis" sort="Glotz, Denis" uniqKey="Glotz D" first="Denis" last="Glotz">Denis Glotz</name>
<name sortKey="Lebbe, Celeste" sort="Lebbe, Celeste" uniqKey="Lebbe C" first="Céleste" last="Lebbé">Céleste Lebbé</name>
<name sortKey="Lebbe, Celeste" sort="Lebbe, Celeste" uniqKey="Lebbe C" first="Céleste" last="Lebbé">Céleste Lebbé</name>
<name sortKey="Lebbe, Celeste" sort="Lebbe, Celeste" uniqKey="Lebbe C" first="Céleste" last="Lebbé">Céleste Lebbé</name>
<name sortKey="Legeai, Camille" sort="Legeai, Camille" uniqKey="Legeai C" first="Camille" last="Legeai">Camille Legeai</name>
<name sortKey="Peraldi, Marie Noelle" sort="Peraldi, Marie Noelle" uniqKey="Peraldi M" first="Marie-Noelle" last="Peraldi">Marie-Noelle Peraldi</name>
<name sortKey="Peraldi, Marie Noelle" sort="Peraldi, Marie Noelle" uniqKey="Peraldi M" first="Marie-Noelle" last="Peraldi">Marie-Noelle Peraldi</name>
<name sortKey="Rerolle, Jean Philippe" sort="Rerolle, Jean Philippe" uniqKey="Rerolle J" first="Jean-Philippe" last="Rerolle">Jean-Philippe Rerolle</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000309 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000309 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:30273235
   |texte=   Kaposi Sarcoma in HIV-positive Solid-Organ Transplant Recipients: A French Multicentric National Study and Literature Review.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:30273235" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a RapamycinFungusV1

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020

	Serveur d'exploration sur la rapamycine et les champignons
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la rapamycine et les champignons

Kaposi Sarcoma in HIV-positive Solid-Organ Transplant Recipients: A French Multicentric National Study and Literature Review.

Kaposi Sarcoma in HIV-positive Solid-Organ Transplant Recipients: A French Multicentric National Study and Literature Review.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki